{"originalText": "，缘于入院前2月因确诊为胃癌，于2014年04月28日在全麻上行腹腔镜辅助上姑息性全胃切除术（D2）。手术顺利。术后病理（病理号201412821），：(全胃)胃-食管交界溃疡型腺神经内分泌癌（G3），累及齿状线，脉管内见癌栓，侵出浆膜外，浆膜外见癌结节，手术标本下切端、上切端及另送(下切端)均未见癌浸润。找到手术标本小弯淋巴结8个，幽门上淋巴结6个，(第7组）淋巴结9个，(第8组）淋巴结1个，(第11组）淋巴结3个及(第12组）淋巴结1个均未见癌转移。手术标本贲门右、贲门左、大弯侧、幽门下均未查见淋巴结。送检(第9组淋巴结)镜上为脉管组织、纤维组织、平滑肌组织、神经组织、脂肪组织及脉管组织。，免疫组化：CD56（+），SY（++），CGA（+），CK18（+++），KI67（35%+），CDX-2（+）。术顺，术后恢复良好,排除化疗禁忌后，于2014.06.01予“奥沙利铂（艾恒）150MGD1+里葆多40MGD2+替吉奥40MGBIDD1-14_”方案化疗1次，过程中患者稍有恶心、呕吐，尚可耐受，予对症处理后症状明显好转出院，此次为化疗再次入院。门诊拟“胃癌术后化疗后”收住入院，出院后饮食、夜休可，大小便如常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 32, "end_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 100}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 393, "label_type": "药物", "overlap": 0, "start_pos": 389}, {"end_pos": 396, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"end_pos": 408, "label_type": "药物", "overlap": 0, "start_pos": 405}, {"end_pos": 418, "label_type": "药物", "overlap": 0, "start_pos": 415}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 490}]}
